ALDH1A3 and breast cancer: Given that CD24−CD44+ cells also have enhanced aerobic glycolytic activity [10], and ALDH1A3 decreases the CD24−CD44+ population (Fig. 1), we hypothesized that ALDH1A3 affects the glucose metabolism of the breast cancer cells.